BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target

Ascentage Pharma Group International Unsponsored ADR

Ascentage Pharma Group International Unsponsored ADR

AAPG

0.00

BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ: AAPG) with a Buy and maintains $48 price target.